Comments
Loading...

Vincerx Pharma

VINCNASDAQ
Logo brought to you by Benzinga Data
$0.2104
0.003301.59%
Pre-Market: 6:43 AM EDT
Consensus Rating1
Buy
Highest Price Target1
$28.00
Lowest Price Target1
$2.00
Consensus Price Target1
$8.80

Vincerx Pharma (NASDAQ:VINC) Stock, Analyst Ratings, Price Targets, Forecasts

Quote.Descriptions.analyst-ratings.

Analyst Trends and Forecast
1
Oct
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Leerink Partners
Chardan Capital
SVB Leerink
B. Riley Securities
HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Vincerx Pharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Vincerx Pharma (VINC) stock?

A

The latest price target for Vincerx Pharma (NASDAQ:VINC) was reported by Leerink Partners on October 8, 2024. The analyst firm set a price target for $2.00 expecting VINC to rise to within 12 months (a possible 850.57% upside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Vincerx Pharma (VINC)?

A

The latest analyst rating for Vincerx Pharma (NASDAQ:VINC) was provided by Leerink Partners, and Vincerx Pharma maintained their outperform rating.

Q

When was the last upgrade for Vincerx Pharma (VINC)?

A

There is no last upgrade for Vincerx Pharma

Q

When was the last downgrade for Vincerx Pharma (VINC)?

A

There is no last downgrade for Vincerx Pharma.

Q

When is the next analyst rating going to be posted or updated for Vincerx Pharma (VINC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vincerx Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vincerx Pharma was filed on October 8, 2024 so you should expect the next rating to be made available sometime around October 8, 2025.

Q

Is the Analyst Rating Vincerx Pharma (VINC) correct?

A

While ratings are subjective and will change, the latest Vincerx Pharma (VINC) rating was a maintained with a price target of $4.00 to $2.00. The current price Vincerx Pharma (VINC) is trading at is $0.21, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch